| Dokumentenart: | Artikel | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Titel eines Journals oder einer Zeitschrift: | Naunyn-Schmiedeberg's archives of pharmacology | ||||||||||||||||||||||||||||
| Verlag: | SPRINGER | ||||||||||||||||||||||||||||
| Ort der Veröffentlichung: | NEW YORK | ||||||||||||||||||||||||||||
| Band: | 387 | ||||||||||||||||||||||||||||
| Nummer des Zeitschriftenheftes oder des Kapitels: | 12 | ||||||||||||||||||||||||||||
| Seitenbereich: | S. 1163-1175 | ||||||||||||||||||||||||||||
| Datum: | 2014 | ||||||||||||||||||||||||||||
| Institutionen: | Chemie und Pharmazie > Institut für Pharmazie > Lehrstuhl Pharmazeutische / Medizinische Chemie II (Prof. Buschauer) | ||||||||||||||||||||||||||||
| Identifikationsnummer: |
| ||||||||||||||||||||||||||||
| Klassifikation: |
| ||||||||||||||||||||||||||||
| Stichwörter / Keywords: | NUCLEOTIDYL CYCLASE ACTIVITY; DEPENDENT PROTEIN-KINASES; SOLUBLE GUANYLYL CYCLASE; CUMP CONCENTRATIONS; CYCLIC-NUCLEOTIDES; CGMP; CELLS; CAMP; CCMP; ANALOGS; cAMP-dependent protein kinase; cGMP-dependent protein kinase; Cyclic CMP; Dibutyryl-cCMP; N-4-monobutyryl-cCMP | ||||||||||||||||||||||||||||
| Dewey-Dezimal-Klassifikation: | 600 Technik, Medizin, angewandte Wissenschaften > 615 Pharmazie 500 Naturwissenschaften und Mathematik > 570 Biowissenschaften, Biologie 600 Technik, Medizin, angewandte Wissenschaften > 615 Pharmazie | ||||||||||||||||||||||||||||
| Status: | Veröffentlicht | ||||||||||||||||||||||||||||
| Begutachtet: | Ja, diese Version wurde begutachtet | ||||||||||||||||||||||||||||
| An der Universität Regensburg entstanden: | Zum Teil | ||||||||||||||||||||||||||||
| Dokumenten-ID: | 33097 |
Web of ScienceZusammenfassung
There is increasing evidence for a role of cytidine 3',5'-cyclic monophosphate (cCMP) as second messenger. In a recent study, we showed that cCMP activates both purified guanosine 3',5'-cyclic monophosphate (cGMP)-dependent protein kinase I alpha (PKG I alpha) and adenosine 3',5'-cyclic monophosphate (cAMP)-dependent protein kinase (PKA) isoenzymes with the regulatory subunits RI alpha and RII ...
Zusammenfassung
There is increasing evidence for a role of cytidine 3',5'-cyclic monophosphate (cCMP) as second messenger. In a recent study, we showed that cCMP activates both purified guanosine 3',5'-cyclic monophosphate (cGMP)-dependent protein kinase I alpha (PKG I alpha) and adenosine 3',5'-cyclic monophosphate (cAMP)-dependent protein kinase (PKA) isoenzymes with the regulatory subunits RI alpha and RII alpha. Moreover, the membrane-permeant cCMP analog dibutyryl (DB)-cCMP induces effective vasodilation and inhibition of platelet aggregation via PKG I alpha, but not via PKA. These data prompted us to conduct a systematic analysis of the effects of cyclic nucleotide (cNMP) analogs on purified PKG I alpha and PKA RI alpha and RII alpha We also studied the effect of DB-cCMP on PKA-dependent phosphorylation of the transcription factor cAMP response-binding protein (CREB) in S49 wild-type lymphoma cells and S49 kin(-) cells, devoid of the catalytic subunit of PKA. The major cellular metabolite of the prodrug DB-cCMP, N-4-monobutyryl (4-MB)-cCMP, was a partial and low-potency activator of purified PKG I alpha and a full and moderate-potency activator of PKA RI alpha and RII alpha. Sp-cCMPS and Sp-cAMPS activated PKA RI alpha and RII alpha with much higher potency and efficacy than PKG I alpha. Molecular modeling suggested that the cytidine ring interacts with PKG I alpha mainly via hydrophobic interactions, while the butyryl group projects away from the kinase. In contrast to DB-cAMP, DB-cCMP did not induce PKA-dependent phosphorylation in intact cells. Taken together, our data show that N-4-monobutyryl-cCMP (4-MB-cCMP) activates PKA RI alpha and PKA RII alpha more potently and with higher efficacy than PKG I alpha in vitro but not in vivo. cNMP phosphorothioates constitute a starting point for the development of PKA activators with high selectivity relative to PKG.
Metadaten zuletzt geändert: 29 Sep 2021 07:40
Altmetric